Answer
Only after review by the specialist team, because formulation choice depends on licensed criteria, swallowing ability and whether a feeding tube is used.
Sources for this answer
- Evrysdi 0.75 mg/mL powder for oral solution — Current selected SmPCemc · Summary of Product Characteristics
- Evrysdi 5 mg film‑coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.